Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis

<div>Validation of the prognostic value of identified biomarkers and associations between key ceRNAs and IC genes. (a) Confirmation of prognostic value of key ceRNAs in HNSCC with different HPV statuses via the TIMER 2.0 database. (b–d) Analysis of associations between key immune cells and OS in HNSCC patients with different HPV statuses based on Cox regression analysis using the TIMER 2.0 database (<a href="http://timer.cistrome.org/">http://timer.cistrome.org/</a>). (e) Differences in expression of IC genes with different HPV statuses in HNSCC using TIMER 2.0. (f) Exploration of the associations between key ceRNAs and IC molecules with different HPV statuses in HNSCC using TIMER 2.0.</div>

BioMed Research International

fig8

Figure 8

Figure 8: Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis 

Figure 8 | Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis 